It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1987.
1987 | Mumbai, Maharashtra, India | ActiveAmstrin Pharma Pvt Ltd, a active private limited company, was established on 23 April 1987 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239MH1987PTC043234. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹6.25 M.
It upholds a compliant status. Its leadership includes Girish Vadilal Shah (Director), Raj Girish Shah (Director). Past directors included Jayantilal Vadilal Shah, Indra Shantilal Jain, Shantilal Javerchand Jain. It holds no open charges and ₹2.10 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.13/D, Kurla Industrial Estate, Nari Seva Sadan Road, Ghatjkopar (West),, Mumbai, Maharashtra, 400086.
U24239MH1987PTC043234
043234
23 April 1987
₹1.50 Cr
₹6.25 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Amstrin Pharma Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Girish Vadilal Shah | Director | 09 Jun 2009 | Current |
| Raj Girish Shah | Director | 03 Aug 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Mar 2022 | Past |
| Pramod Abcsdd | Director | 09 Jun 2009 | Past |
| Pramod Abcsdd | Director | 24 May 2019 | Past |
| Pramod Abcsdd | Director | 24 May 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amstrin Pharma Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 10.6% increase. The company also saw a slight decrease in profitability, with a 2.32% decrease in profit. The company's net worth moved up by a moderate rise of 6.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Amstrin Pharma had a public holding of 4.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹20,990,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 1998 | State Bank Of India | ₹7.62 M | Satisfied |
| 29 Jul 1997 | State Bank Of India | ₹5.00 M | Satisfied |
| 13 May 1995 | State Bank Of India | ₹2.50 M | Satisfied |
| 26 Jul 1990 | State Bank Of India | ₹5.87 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Amstrin Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Amstrin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amstrin Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Amstrin Pharma Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Amstrin Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity Raj Girish Shah was appointed as a Director was appointed as a Director on 03 Aug 2019 & has been associated with this company since 6 years 3 months . was completed.
Girish Vadilal Shah was appointed as a Director was appointed as a Director on 09 Jun 2009 & has been associated with this company since 16 years 5 months . was recorded as a recent event.
The activity A charge registered on 12 Apr 1998 via Charge ID 90226185 with State Bank Of India was fully satisfied on 31 Oct 2007. was completed.
Progress on A charge registered on 29 Jul 1997 via Charge ID 90226143 with State Bank Of India was fully satisfied on 31 Oct 2007. was documented.
The CIN of Amstrin Pharma Pvt Ltd is U24239MH1987PTC043234.
Amstrin Pharma Pvt Ltd is headquartered at Plot No.13/D, Kurla Industrial Estate, Nari Seva Sadan Road, Ghatjkopar (West),, Mumbai, Maharashtra, 400086.
Amstrin Pharma Pvt Ltd was incorporated on 23 April 1987.
The current directors of Amstrin Pharma Pvt Ltd are
The primary industry of Amstrin Pharma Pvt Ltd is Pharma.
Amstrin Pharma Pvt Ltd is unlisted.
The authorized capital of Amstrin Pharma Pvt Ltd is ₹1.50 Cr, and the paid-up capital is ₹6.25 M.
The compliance status of Amstrin Pharma Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX